BSD Medical Corp.

Dennis P. Gauger (Chief Financial Officer / Secretary) CPA, has served as Chief Financial Officer since May 2007. Mr. Gauger is a licensed Certified Public Accountant in Utah and Nevada. He has led our Sarbanes – Oxley internal controls compliance and directs our external financial and SEC reporting. He also assists with investor relations activities, including press releases and investor communications. Prior to his full time employment with BSD Medical Corporation, he served several public and private companies in a variety of industries as a part-time, contract financial executive, corporate troubleshooter and consultant. Previously, Mr. Gauger worked for Deloitte & Touche LLP, an international accounting and consulting firm, for 22 years, including 9 years as an accounting and auditing partner. He is a member of the American Institute of Certified Public Accountants and the Utah Association of Certified Public Accountants.

Dixie Toolson Sells (VP Regulatory Affairs) joined BSD Medical in 1978 and has directed the company’s regulatory affairs since 1984. Her efforts were largely instrumental in obtaining recent FDA approval for TherMatrx, Inc., and she currently leads the project to obtain approval for the BSD-2000. She also serves on the Board of Directors of the Utah Intermountain Biomedical Association.

Richard A. White, MBA, (VP of Business Development) has been deeply involved in business development and growth since obtaining his degree in international business at The Garvin School of International Management "Thunderbird" in 1980. He has played a key role in the founding of new companies, has led a national sales organization selling large capital equipment in power control systems and served as International Sales Manager for Merit Medical Systems, a leading manufacturer and marketer of products used in diagnostic and interventional cardiology and radiology procedures.

J. Richard Faux (Director of Operations) joined the company in 1981 and leads BSD’s FDA compliant and ISO-9000 certified manufacturing facility.

Dr. Mark Hagmann (Senior Engineer) joined BSD in 2000. He holds an undergraduate degree in physics and a PhD in electrical engineering. He has occupied important posts in universities and as a Senior Staff Fellow for the National Institutes of Health. Having published well over 100 articles in peer-reviewed journals, his expertise includes hyperthermia, lasers, microwave sciences and biotechnology.

Brian L. Ferrand (VP of Sales) Joined BSD in 2005 as Vice President of Sales. Previously Mr. Ferrand served as Vice President of Sales and as a corporate officer of Merit Medical Systems, Inc. (a company traded on NASDAQ) from 1993 until October 2004. Previously Mr. Ferrand served as Director of Sales from 1992 to 1993 and as a National Sales Manager from 1991-1992 for Merit Medical. Merit Medical Systems is a producer of medical products used in cardiology and radiology sold on a worldwide basis.

Gerhard W. Sennewald, Ph.D., has served as a director of BSD since 1994. Dr. Sennewald has served as the President and Chief Executive Officer of Medizin-Technik GmbH, of Munich, Germany, a firm which is engaged in the business of distributing hyperthermia equipment and diagnostic imaging equipment and services, from April 1985 to the present. In connection with his service to Medizin-Technik GmbH, Dr. Sennewald has been BSD's key European representative and distributor for 17 years and has been instrumental in obtaining the majority of BSD's foreign sales. He also serves on the Board of Directors of TherMatrx, Inc.

Paul F. Turner, MSEE (Chairman/Senior VP/Chief Technology Officer) joined BSD Medical Corporation in 1978 after seven years as a respected developer of microwave communications systems for Sperry Univac (now L3 Communications). His experience with advanced military defense communication systems prepared him to lead the development of sophisticated phased array microwave technology at BSD Medical. Mr. Turner has led the design of microwave treatment systems for tumors, including the development of external phased array antenna technology to focus radiated microwave energy deep into the central area of the body to treat deep tumors. He has also integrated this novel technology with Magnetic Resonance Imaging (MRI) to non-invasively monitor treatments within the patient's body.

Steven G. Stewart (Director) CPA, served as Chief Financial Officer for Headwaters, Inc. (a New York Exchange Company) from July 1998 until October 2005 when he became the Treasurer. Previously, Mr. Stewart served as a business assurance partner for PricewaterhouseCoopers LLP (formerly Coopers & Lybrand LLP), and as an audit partner with Ernst & Young (formerly Arthur Young), including service as the Director of High Technology and Entrepreneurial Services for the Salt Lake City office.